Video: Forbion's Slootweg On Investment Focus For New €120m+ Fund
This article was originally published in Scrip
Sander Slootweg, managing partner at Forbion Capital Partners, speaks to Mike Ward, global director of content for Informa Pharma Insights, at the recent BIO-Europe partnering meeting in Munich, Germany, about the venture capital firm's new €120m+ fund dedicated to life science projects. They discuss geographical focus for the cash, potential companies of interest and successful exit strategies.
Register for our free email digests: